Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly

INTRODUCTION: Treatment of acromegaly resistant to first generation somatostatin analogues (first gen-SSA) is often difficult. We aimed to investigate the role of partial response and resistance to first gen-SSA in the choice of second line treatments and their outcomes. PATIENTS AND METHODS: A retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiloiro, Sabrina, Costa, Denise, Lauretta, Rosa, Mercuri, Valeria, Sbardella, Emilia, Samperi, Irene, Appetecchia, Marialuisa, Bianchi, Antonio, Giampietro, Antonella, Gargiulo, Patrizia, Isidori, Andrea M., Poggi, Maurizio, Pontecorvi, Alfredo, De Marinis, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584996/
https://www.ncbi.nlm.nih.gov/pubmed/35986839
http://dx.doi.org/10.1007/s12020-022-03158-w

Ejemplares similares

Ejemplares similares